Mislabeling and Status of Semisynthetic Kratom-Derived Products in the US Market.

Gour A, Kanumuri SRR, Mukhopadhyay S, Pullman MK, León F, Cutler SJ, McCurdy CR, Sharma A

Open source

DOI
10.1002/dta.70122
Published
2026 Oct
Container
Drug testing and analysis
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/dta.70122,
  title = {Mislabeling and Status of Semisynthetic Kratom-Derived Products in the US Market.},
  author = {Gour A and Kanumuri SRR and Mukhopadhyay S and Pullman MK and León F and Cutler SJ and McCurdy CR and Sharma A},
  year = {2026},
  journal = {Drug testing and analysis},
  doi = {10.1002/dta.70122},
  url = {https://doi.org/10.1002/dta.70122}
}

RIS

TY  - JOUR
TI  - Mislabeling and Status of Semisynthetic Kratom-Derived Products in the US Market.
AU  - Gour A
AU  - Kanumuri SRR
AU  - Mukhopadhyay S
AU  - Pullman MK
AU  - León F
AU  - Cutler SJ
AU  - McCurdy CR
AU  - Sharma A
PY  - 2026
JO  - Drug testing and analysis
DO  - 10.1002/dta.70122
UR  - https://doi.org/10.1002/dta.70122
ER  - 

APA

A, G., SRR, K., S, M., MK, P., F, L., SJ, C., CR, M., & A, S. (2026). Mislabeling and Status of Semisynthetic Kratom-Derived Products in the US Market.. Drug testing and analysis. https://doi.org/10.1002/dta.70122

Source records